查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2059313

生物製藥生產設備及耗材市場：市場洞察、競爭格局及市場預測（2034 年）

Biopharmaceutical Processing Equipment & Consumables - Market Insights, Competitive Landscape, and Market Forecast - 2034
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

生物製藥生產設備及耗材市場概述

  • 全球生物製藥生產設備和耗材市場預計將從 2025 年的 521.7243 億美元成長到 2034 年的 1,164.5628 億美元，展現出強勁且持續的成長勢頭。
  • 全球生物製藥生產設備和耗材市場預計在 2026 年至 2034 年的預測期內將以 9.38% 的複合年成長率成長。
  • 生物製藥和先進治療方法的需求日益成長，加上慢性病和遺傳性疾病的盛行率不斷上升，正顯著加速單株抗體、疫苗和標靶治療等複雜治療方法的研發和商業化。同時，細胞和基因療法以及個人化醫療的快速發展，正推動生產轉向小規模、更專業、更柔軟性的生產系統。這些趨勢共同推動了對先進生物製藥生產設備（如生物反應器、過濾系統和層析法系統）以及高品質耗材（如一次性組件、培養基和樹脂）的需求。這是因為製造商需要擴充性、無菌且高效的解決方案，以滿足不斷變化的治療需求。
  • 在生物製藥生產設備和耗材市場運作的主要公司包括：賽默飛世爾科技公司、賽多利斯公司、Cytiva公司、默克集團、Eppendorf公司、龍沙集團、Repligen公司、Avantor公司、康寧公司、丹納赫公司、Getinge AB公司、GEA集團、ABEC、PBS Biotechration Products公司、Entegris公司、聖戈班生命科學公司、派克漢尼汾公司、安捷倫科技公司和Bio-Rad Laboratories公司。
  • 北美預計將成為生物製藥生產設備和耗材市場的主要驅動力，這得益於其成熟的生物製藥產業、賽默飛世爾科技公司、丹納赫公司和Cytiva等領先製造商的強大市場地位、高額的研發投入以及先進的生產基礎設施。此外，該地區還受益於有利的監管支持、一次性技術的快速普及以及對生物製藥和細胞/基因療法日益成長的需求，這些因素進一步鞏固了其市場主導地位。
  • 在生物製藥生產設備和耗材市場按產品類型分類的細分市場中，預計到 2025 年，過濾系統類別將佔最大的市場佔有率。

推動生物製藥生產設備和耗材市場成長的因素

  • 生物製藥和先進治療方法需求的不斷成長，正推動生物製藥生產設備和耗材需求的激增：單株抗體、疫苗、重組蛋白以及細胞和基因療法等生物製藥產品的日益普及，是該市場的主要成長要素。這些治療方法需要複雜且高度可控的生產環境，這直接增加了對先進生物製程製程設備和耗材的需求。
  • 慢性病和遺傳性疾病盛行率上升：慢性病（癌症、自體免疫疾病）和罕見遺傳性疾病在全球日益加重，加速了生物製藥的發展。反過來，這又推動了對大規模和小批量生物製造基礎設施的需求，增加了對設備和耗材的需求。
  • 細胞和基因療法以及個人化醫療的快速發展：CAR-T療法、基因療法和個人化醫療等新興治療方法需要小批量、高價值的生產，以及密封無菌的系統和靈活的模組化設備。這促使對一次性系統和專用耗材的需求顯著增加，進而推動了生物製藥生產設備和耗材市場的整體擴張。

生物製藥生產設備及耗材市場報告細分

本生物製藥生產設備及耗材市場報告全面概​​述了全球生物製藥生產設備及耗材市場，揭示了關鍵趨勢、成長要素、挑戰和機會。該報告按產品類型、工作流程階段、應用和地區進行了詳細的市場細分，並深入分析了北美、歐洲和亞太等主要市場的競爭格局、監管環境和市場動態。參與企業關鍵數據，幫助其識別市場潛力、制定策略規劃，並掌握快速成長的生物製藥生產設備及耗材市場中的新興機會。

生物製藥生產設備和耗材是指用於開發、生產、純化和包裝生物製藥（例如疫苗、單株抗體以及細胞和基因療法）的工具、系統和一次性材料。設備包括生物反應器、過濾系統和層析法系統等儀器，而耗材包括過濾器、樹脂、培養基、管路和生物製程容器等一次性產品。這些設備和耗材共同實現了生技藥品在上游工程、下游和填充/表面處理工程等各個環節的高效、可擴展和無菌生產。

在生物製藥和先進治療方法需求不斷成長，以及慢性病和遺傳性疾病患病率日益上升的推動下，單株抗體、疫苗和標靶治療等複雜治療方法的研發和商業化進程正在顯著加速。隨著藥物研發管線日益轉向生物製藥（其生產流程比傳統小分子藥物更為複雜），生產者需要具備高度可控且嚴謹的生產環境。同時，細胞和基因療法以及個人化醫療的快速發展正在改變生產模式，使其從大規模標準化生產轉向小規模、以患者為中心且高度柔軟性的系統，這些系統對精準性、無菌性和擴充性提出了更高的要求。

這些趨勢共同推動了對先進生物製藥生產設備的強勁需求，例如生物反應器、過濾系統和層析法平台，這些設備對於細胞培養、純化和最終產品品質至關重要。同時，為了確保無污染操作、快速週轉和經濟高效的生產，對高品質耗材（例如一次性組件、培養基、樹脂和過濾組件）的依賴性也日益增強。此外，向一次性和模組化技術的轉變使製造商能夠快速回應不斷變化的生產需求，減少驗證要求，並提高營運效率。因此，這些因素共同推動了設備和耗材投資的顯著成長，從而促進了生物製藥生產市場的整體成長。

生物製藥生產設備及耗材市場的最新市場動態與趨勢為何？

生物製藥和先進治療方法日益成長的需求是推動生物製藥生產設備和耗材市場成長的主要驅動力。這是因為與傳統的小分子藥物相比，這些治療方法的生產本身就更加複雜、精細且耗費資源。單株抗體、疫苗和重組蛋白等生物製藥產品需要高度可控的環境、多步驟純化製程和嚴格的無菌標準。這直接增加了對生物反應器、過濾系統和層析法平台等先進設備以及一次性組件、培養基和樹脂等高品質耗材的需求。隨著全球生物製藥產品線的擴展，製造商正在提高產能並大力投資最先進的生物製程基礎設施。

例如，2025年2月，賽默飛世爾科技公司宣布將以約41億美元收購一家純化和過濾業務公司。此舉將鞏固該公司在生物加工下游領域的地位，並直接滿足日益成長的生物製藥純化技術需求。此外，2025年7月，該公司收購了賽諾菲的製造地，擴大了其無菌填充生產能力。這反映了市場對大規模生物製藥生產的需求不斷成長。

此外，慢性病和遺傳性疾病的增加進一步擴大了生物製藥加工設備和耗材的整體市場。根據國際癌症研究機構（IARC，2026）提供的數據，預計到2045年，全球將新增約3,260萬例癌症病例。癌症發生率的上升顯著推動了生物製藥加工設備和耗材市場的發展，因為腫瘤學仍然是生物製藥（如單株抗體、免疫療法和細胞療法）最大的應用領域之一。隨著全球癌症診斷數量的增加，對先進標靶治療方法的需求日益成長，從而帶動了生物製藥產量的增加。這推動了對先進生產設備（如生物反應器、過濾系統和層析法系統）以及耗材（如一次性組件、培養基和樹脂）的需求。此外，包括CAR-T療法在內的個人化癌症療法的興起，進一步加速了對柔軟性、無菌且擴充性的生物製造解決方案的需求，從而推動了整體市場成長。因此，基於上述因素，預計生物製藥加工設備及耗材的整體市場在預測期內將持續擴張。

然而，除了污染和產品損失的風險外，法規和合規的複雜性也對生物製藥生產設備和耗材市場構成重大阻礙因素。生物製藥生產極為精細，即使是輕微的污染也可能導致整批產品報廢，造成巨大的經濟損失和生產延誤。因此，必須嚴格使用高品質的設備和耗材，這增加了成本和營運負擔。同時，FDA和EMA等監管機構的嚴格要求也要求對設備和耗材進行廣泛的驗證、文件記錄和品質保證流程，使得實施過程耗時耗力。這些因素綜合起來會導致實施延誤，尤其對於中小製造商而言，這可能會阻礙高效且擴充性的生物製藥生產。

生物製藥生產設備及耗材市場區隔分析。

生物製藥生產設備及耗材市場－依產品類型、工作流程階段、應用及地區分類

生物製藥生產設備及耗材市場區域分析

北美生物製藥生產設備與耗材市場趨勢

預計到2025年，北美將佔生物製藥生產設備和耗材市場38%的最大佔有率。北美預計將主導市場，原因在於其高度發展的生物製藥生態系統、眾多領先製造商的強大實力、先進的生產基礎設施以及對生物製藥生產和創新持續不斷的投資。該地區，尤其是美國，聚集了大量的生物製藥和生物技術公司，這些公司是生物製程設備和耗材的主要終端用戶，它們大量採購這些產品用於臨床和商業規模的生產。此外，政府對生物技術和生物製造的大力支持，以及對單株抗體、疫苗、細胞和基因療法等生物製藥產品日益成長的需求，正在推動產能的持續擴張和一次性系統、自動化生物製程平台等先進技術的應用。該地區還擁有成熟的供應鏈、熟練的勞動力資源以及創新解決方案的快速應用等優勢，進一步鞏固了其主導地位。

近期公司在北美的具體發展進一步凸顯了這一優勢，這些發展表明公司持續增加投資並擴大產能。例如，2025年6月，Cytiva完成了16億美元全球投資計畫的一部分，其中包括在美國的擴張，以增強其生物製程製造能力，這反映出該地區對設備和耗材的強勁需求。

此外，丹納赫公司和賽默飛世爾科技公司等企業正透過技術創新和基礎設施投資，持續加強在北美地區的地位，旨在支持下一代治療方法。這種持續的投資，加上對生物製藥和創新產品的強勁需求，進一步鞏固了北美在全球生物製藥生產設備和耗材市場的主導地位。

歐洲生物製藥生產設備與耗材市場趨勢

歐洲生物製藥生產設備和耗材市場正經歷強勁且永續的成長，這主要得益於該地區強大的生物製藥生產基礎設施、不斷成長的生物製藥生產投資以及健全的法規環境和創新生態系統。歐洲擁有多家領先的生物製程解決方案供應商，例如賽多利斯公司（Sartorius AG）和賽迪瓦公司（Cytiva），以及一個成熟的製藥公司和合約研發生產機構（CDMO）網路，這些機構不斷擴大產能，以滿足日益成長的生物製藥、疫苗和先進治療方法需求。此外，有利的法規結構以及對永續和連續生物製程技術的日益重視，正在推動全部區域先進設備和高價值耗材的普及應用。熟練人才的儲備、強大的研發基礎設施以及不斷成長的生產外包業務也促進了市場擴張。

這一成長也得益於近期歐洲各公司的具體發展。例如，Cytiva於2025年6月完成了大規模的產能擴張計劃，其中包括大幅提升其位於瑞典烏普薩拉的層析法樹脂產量，旨在加強區域供應鏈，滿足日益成長的生物製藥需求。同樣，Sartorius AG於2026年2月宣布投資約4.42億歐元，用於擴大其生物製程生產能力，包括其歐洲工廠，並專注於先進的過濾技術和永續。此外，PCI Pharma Services於2024年9月宣布擴建其位於愛爾蘭都柏林的包裝和設備組裝工廠，旨在增強其商業規模的生物製藥包裝和低溫運輸能力。

歐洲主要國家的持續投資和基礎設施擴建顯示該地區致力於加強其生物製造能力，從而推動生物製藥加工設備和耗材市場的持續成長。

亞太地區生物製藥生產設備及耗材市場趨勢

亞太地區正崛起為生質製藥生產設備和耗材市場的主要驅動力，這主要得益於生物製藥產能的快速擴張、生物技術投資的增加以及對生物製藥和生物類似藥日益成長的需求。中國、印度、韓國和日本等國家在政府扶持、有利的監管政策和生產成本優勢的支持下，本地生物製藥生產正經歷顯著成長。合約研發生產機構（CDMO）的日益增多、臨床試驗活動的增加以及醫療基礎設施的不斷完善，進一步推動了對先進生物製程設備和耗材的需求。此外，三星生物製劑和藥明康德等全球性企業正在該地區大力投資建設大規模生物製藥生產設施，從而加強供應鏈並加速一次性技術和尖端生物製程系統的應用。這些因素共同作用，使亞太地區成為全球市場領先的高成長區域。

生物製藥生產設備和耗材市場的主要參與者有哪些？

以下是生物製藥生產設備及耗材市場的主要企業。這些企業通常佔最大的市場佔有率，並引領產業趨勢。

  • Thermo Fisher Scientific Inc.
  • Sartorius AG
  • Cytiva
  • Merck KGaA
  • Eppendorf SE
  • Lonza Group AG
  • Repligen Corporation
  • Avantor, Inc.
  • Corning Incorporated
  • Danaher Corporation
  • Getinge AB
  • GEA Group AG
  • ABEC, Inc.
  • PBS Biotech, Inc.
  • Meissner Filtration Products, Inc.
  • Entegris, Inc.
  • Saint-Gobain Life Sciences
  • Parker-Hannifin Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • 其他

競爭格局如何影響生物製藥生產設備和耗材市場？

生物製藥生產設備和耗材市場的競爭格局呈現中等程度的集中化，少數全球領導者主導核心技術領域，而眾多中型和區域性企業則在細分市場和耗材領域展開激烈競爭。賽默飛世爾科技公司（Thermo Fisher Scientific Inc.）、丹納赫公司（Danaher，包括Cytiva）、默克集團（Merck KGaA）和賽多利斯公司（Sartorius AG）等領先企業憑藉涵蓋生物反應器、過濾系統、層析法和一次性使用技術的全面產品系列，以及全球生產和分銷能力，確立了強大的市場地位。這些公司主要透過技術創新、整合解決方案和長期服務合約展開競爭，通常提供端到端的生物製程平台，這增加了客戶的依賴性和轉換成本。同時，隨著中型和新興企業專注於細胞和基因治療、一次性使用耗材和模組化系統等專業領域，並以經濟高效且靈活的解決方案挑戰現有領先領導企業，競爭日益激烈。

此外，隨著企業致力於提昇技術能力並拓展企業發展，市場策略活動日益活躍，包括併購、與合約研發生產機構（CDMO）建立合作關係以及擴大產能。自動化、數位化生物製程、連續生產和封閉式系統技術等領域的創新正成為關鍵的差異化因素，企業正大力投資研發，以提高製程效率和擴充性。此外，來自低成本製造商（尤其是在亞洲）日益激烈的競爭，給老牌企業帶來了價格壓力，迫使它們透過整合附加價值服務、品質保證和先進的分析能力來實現差異化。整體而言，競爭格局正朝著大型企業整合與新興企業創新主導競爭相結合的方向發展，這兩者共同塑造著生物製藥生產設備和耗材市場的成長、技術進步和策略定位。

生物製藥生產設備及耗材市場的最新趨勢

  • 2026 年 2 月，賽多利斯股份公司宣布已投資約 4.42 億歐元擴大其生物製程生產能力，包括在歐洲的設施，重點是先進的過濾技術和永續解決方案。
  • 2025年2月，賽默飛世爾科技公司宣布將以約41億美元收購純化和過濾業務。此舉將鞏固公司在下游生物製程的地位，並直接滿足日益成長的生物製劑純化技術需求。
  • 2025 年 7 月，賽默飛世爾科技公司從賽諾菲收購了製造地，以擴大其無菌填充生產能力，這反映了對大規模生物製藥生產日益成長的需求。

生物製藥生產設備及耗材的市場區隔

  • 生物製藥生產設備和耗材市場趨勢（按產品類型分類）
  • 裝置
  • 生物反應器
  • 過濾系統
  • 層析法系統
  • 離心分離器和分離器
  • 其他
  • 消耗品
  • 生物製藥生產設備及耗材依工作流程階段分類
  • 上游工程
  • 下游工藝
  • 配方、填充和成品
  • 品管和分析測試
  • 按應用領域分類的生物製藥生產設備和耗材指南。
  • 單株抗體（mAbs）
  • 疫苗
  • 重組蛋白
  • 細胞和基因治療
  • 其他
  • 生物製藥生產設備和耗材最終用戶的暴露情況
  • 生物製藥和製藥公司
  • 合約研發生產組織（CDMO）
  • 學術和研究機構
  • 生物製藥生產設備和耗材的區域趨勢
  • 北美生物製藥生產設備及耗材市場
  • 美國生物製藥生產設備及耗材市場
  • 加拿大生物製藥生產設備和耗材市場
  • 墨西哥生物製藥生產設備及耗材市場
  • 歐洲生物製藥生產設備及耗材市場
  • 英國生物製藥生產設備及耗材市場
  • 德國生物製藥生產設備及耗材市場
  • 法國生物製藥生產設備及耗材市場
  • 義大利生物製藥生產設備及耗材市場
  • 西班牙生物製藥生產設備及耗材市場
  • 其他歐洲國家對生物製藥生產設備和耗材的需求市場
  • 亞太地區生物製藥生產設備及耗材市場
  • 中國生物製藥生產設備及耗材市場
  • 日本生物製藥生產設備及耗材市場
  • 印度生物製藥生產設備及耗材市場
  • 澳洲生物製藥生產設備和耗材市場
  • 韓國生物製藥生產設備及耗材市場
  • 亞太地區其他生物製藥生產設備及耗材市場
  • 世界其他地區的生物製藥生產設備和耗材市場
  • 南美洲生物製藥生產設備及耗材市場
  • 中東生物製藥生產設備及耗材市場
  • 非洲生物製藥生產設備及耗材市場

影響分析

人工智慧驅動的創新與應用：

人工智慧驅動的創新正在迅速改變生物製藥生產設備和耗材市場，使整個生物製程的生產更加智慧、快速和高效。人工智慧 (AI) 和機器學習 (ML) 被整合到生物反應器、過濾系統和分析儀器等設備中，從而實現即時製程監控、預測控制和自動化決策。例如，人工智慧驅動的「軟感測器」整合來自多個數據來源的數據，以估算細胞密度、代謝物水平和產品品質屬性等關鍵參數，從而實現早期干預並提高製程穩定性。在上游工程，人工智慧模型最佳化細胞培養條件（溫度、pH 值、營養水平等），以最大限度地提高產量並減少批次失敗。在下游，人工智慧提高了純化效率和製程一致性。

此外，人工智慧正被廣泛應用於生物製程設備的預測性維護，其中演算法分析感測器和物聯網數據以預測設備故障，從而最大限度地減少停機時間並提高運行效率。在品管，人工智慧驅動的電腦視覺和異常檢測系統可實現自動化檢測，確保符合嚴格的監管標準，同時減少人為錯誤。數位雙胞胎、生成式人工智慧和進階分析平台等新興應用領域正在推動基於模擬的製程最佳化、需求預測和供應鏈管理，從而降低成本並擴充性。總而言之，人工智慧驅動的創新在提升生物製藥製造效率、產品品質、合規性和柔軟性發揮著至關重要的作用，並且是下一代生物製造系統的主要驅動力。

美國關稅對生物製藥生產設備和耗材市場的影響分析：

美國關稅對生物製藥生產設備和耗材市場的影響，正在造成成本壓力、供應鏈中斷和產業戰略重組之間錯綜複雜的相互作用。近期推出的關稅政策，包括對醫療設備和工業原料徵收約10%的基本進口關稅，以及在某些國家徵收更高的關稅（高達20-50%甚至更高），都推高了進口生物程序設備、組件和耗材（例如過濾器、管路和一次性系統）的成本。由於生物製藥產業高度依賴全球一體化的原料、組件和專用設備供應鏈，這些不斷上漲的投入成本正直接影響製造商和合約研發生產機構（CDMO）。

此外，諸如提案對品牌藥品進口徵收100%關稅（除非企業投資在美國建廠，否則該關稅將於2025年10月生效）等政策措施，正迫使企業將生產遷回國內或擴大國內生產設施，從而促使對在地採購生物程序設備和耗材的需求增加。然而，這種轉變也帶來了一些短期挑戰，例如資本投資增加、推出週期延長以及供應瓶頸，尤其對於那些依賴進口技術的企業而言更是如此。關稅也會加劇營運的不確定性和價格波動，迫使企業重新評估其籌資策略、實現供應商多元化並投資建造區域製造地。

總體而言，雖然美國關稅推高了成本並擾亂了全球供應鏈，但它們也刺激了國內製造業、供應鏈本地化以及對美國生物程序基礎設施的長期投資，從而重塑了生物製藥工藝設備和耗材市場的競爭力和成長軌跡。

這項分析能為客戶帶來哪些好處？

  • 成本管理：透過了解關稅趨勢，客戶可以預測成本上漲，並據此調整定價策略，以確保盈利。
  • 供應鏈最佳化：透過尋找替代來源並實現供應鏈多元化，客戶可以減少對高關稅地區的依賴，增強自身抵禦能力。
  • 監管合規：專家指導幫助客戶應對不斷變化的法規環境，從而保持合規並避免潛在的法律挑戰。
  • 策略規劃：深入了解關稅的影響，使客戶能夠就製造地、夥伴關係和打入市場策略做出明智的決策。

生物製藥生產設備及耗材市場報告要點

  • 生物製藥生產設備和耗材的當前市場規模分析（2025 年）和 8 年市場預測（2026-2034 年）。
  • 過去三年發生的主要產品和技術開發、併購、合作和合資企業
  • 主導生物製藥生產設備和耗材市場的主要公司
  • 生物製藥生產設備和耗材市場為其他競爭者提供了各種機會。
  • 哪些細分市場在2025年表現最佳？這些細分市場在2034年又會呈現哪些趨勢？
  • 目前生物製藥生產設備和耗材市場中，哪個地區或國家的表現最佳？
  • 企業在生物製藥生產設備和耗材市場尋求未來成長機會時，應該重點關注哪些地區和國家？

關於生物製藥生產設備和耗材市場的常見問題

1. 生物製藥生產設備和耗材市場的成長率是多少？

  • 預計從 2026 年到 2034 年的預測期內，生物製藥生產設備和耗材市場將以 9.38% 的複合年成長率成長。

2. 生物製藥生產設備及耗材市場屬於哪一種類型的市場？

  • 全球生物製藥生產設備和耗材市場預計將從 2025 年的 521.7243 億美元成長到 2034 年的 1164.5628 億美元。

3. 哪個地區在生物製藥生產設備和耗材市場中佔最大的市場佔有率？

  • 北美預計將成為生物製藥生產設備和耗材市場的主要驅動力，這得益於其成熟的生物製藥產業、賽默飛世爾科技公司、丹納赫公司和Cytiva等領先製造商的強大市場地位、高額的研發投入以及先進的生產基礎設施。此外，該地區還受益於有利的監管支持、一次性技術的快速普及以及對生物製藥和細胞/基因療法日益成長的需求，這些因素進一步鞏固了其市場主導地位。

4. 生物製藥生產設備和耗材市場的成長要素是什麼？

  • 生物製藥和先進治療方法的需求不斷成長，加上慢性病和遺傳性疾病的日益普遍，正顯著加速單株抗體、疫苗和標靶治療等複雜治療方法的研發和商業化。同時，細胞和基因療法以及個人化醫療的快速發展，正推動生產轉向小規模、更專業、更柔軟性的生產系統。這些趨勢共同催生了對先進生物製藥生產設備的強勁需求，包括生物反應器、過濾系統和層析法系統，以及高品質的耗材，例如一次性組件、培養基和樹脂。這是因為製造商需要擴充性、無菌且高效的解決方案，以滿足不斷變化的治療需求。

5. 生物製藥生產設備和耗材市場的主要企業有哪些？

  • 生物製藥生產設備和耗材市場的主要參與企業包括賽默飛世爾科技公司（Thermo Fisher Scientific Inc.）、賽多利斯公司（Sartorius AG）、Cytiva公司、默克集團（Merck KGaA）、愛本多夫公司（Eppendorf SE）、龍沙集團（Lonza Group AG）、普利普利根。 Incorporated）、丹納赫公司（Danaher Corporation）和Getinge AB公司。其他值得關注的參與者包括GEA集團（GEA Group AG）、ABEC公司、PBS Biotech公司、邁斯納過濾產品公司（Meissner Filtration Products, Inc.）、恩特格里斯公司（Entegris, Inc.）、聖戈班生命科學公司（Saint-Gobain Life Sciences）、Park漢尼汾公司（Parker Technologies Corporation）科技公司（Hgilmin Life Sciences. Laboratories公司。

目錄

第1章：生物製藥生產設備及耗材市場報告概述

第2章：生物製藥生產設備與耗材市場摘要整理

第3章：生物製藥生產設備及耗材市場關鍵因素分析

  • 生物製藥生產設備和耗材的市場促進因素
    • 對生技藥品和先進治療方法的需求日益成長
    • 慢性病和遺傳疾病的盛行率
    • 細胞和基因治療以及個人化醫療的快速發展
  • 抑制生物製藥生產設備和耗材市場發展的因素和挑戰。
    • 污染和產品損失的風險
    • 監管和合規的複雜性
  • 生物製藥生產設備和耗材市場的機遇
    • 人工智慧、自動化和數位生物程序整合

第4章：影響分析

  • 人工智慧驅動的創新和應用
  • 美國關稅影響分析

第5章：監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第6章：生物製藥生產設備及耗材市場的波特五力分析

第7章：生物製藥生產設備與耗材市場評估

  • 依產品類型
    • 裝置
    • 消耗品
  • 工作流程階段
    • 上游工程
    • 下游工藝
    • 配方和填充/成品
    • 品管和分析測試
  • 用途別
    • 單株抗體（mAbs）
    • 疫苗
    • 重組蛋白
    • 細胞和基因治療
    • 其他
  • 最終用戶
    • 生物製藥和製藥公司
    • 受託製造廠商（CDMO）
    • 學術和研究機構
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 競爭情勢

第9章：創業資金籌措與投資趨勢

第10章：生物製藥生產設備及耗材市場中的公司與產品概況

  • Thermo Fisher Scientific Inc.
  • Sartorius AG
  • Cytiva（Danaher Corporation）
  • Merck KGaA
  • Eppendorf SE
  • Lonza Group AG
  • Repligen Corporation
  • Avantor, Inc.
  • Corning Incorporated
  • Danaher Corporation
  • Getinge AB
  • GEA Group AG
  • ABEC, Inc.
  • PBS Biotech, Inc.
  • Meissner Filtration Products, Inc.
  • Entegris, Inc.
  • Saint-Gobain Life Sciences
  • Parker-Hannifin Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

第11章：KOL的觀點

第12章 專案方法

第13章：關於 DelveInsight

第14章 免責聲明與聯絡方式

Product Code: DIMDCL0909

Biopharmaceutical Processing Equipment & Consumables Market Summary

  • The global biopharmaceutical processing equipment & consumables market is expected to increase from USD 52,172.43 million in 2025 to USD 116,456.28 million by 2034, reflecting strong and sustained growth.
  • The global biopharmaceutical processing equipment & consumables market is growing at a CAGR of 9.38% during the forecast period from 2026 to 2034.
  • The rising demand for biologics and advanced therapies, combined with the increasing prevalence of chronic and genetic diseases, is significantly accelerating the development and commercialization of complex treatments such as monoclonal antibodies, vaccines, and targeted therapies. At the same time, the rapid growth of cell & gene therapy and personalized medicine is shifting manufacturing toward smaller, highly specialized, and flexible production systems. Together, these trends are driving strong demand for advanced biopharmaceutical processing equipment such as bioreactors, filtration, and chromatography systems, as well as high-quality consumables like single-use assemblies, media, and resins, as manufacturers require scalable, sterile, and efficient solutions to meet evolving therapeutic needs.
  • The leading companies operating in the biopharmaceutical processing equipment & consumables market include Thermo Fisher Scientific Inc., Sartorius AG, Cytiva, Merck KGaA, Eppendorf SE, Lonza Group AG, Repligen Corporation, Avantor, Inc., Corning Incorporated, Danaher Corporation, Getinge AB, GEA Group AG, ABEC, Inc., PBS Biotech, Inc., Meissner Filtration Products, Inc., Entegris, Inc., Saint-Gobain Life Sciences, Parker-Hannifin Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., and others.
  • North America is expected to dominate the biopharmaceutical processing equipment & consumables market due to its well-established biopharmaceutical industry, strong presence of leading manufacturers such as Thermo Fisher Scientific, Danaher Corporation, and Cytiva, high R&D investments, and advanced manufacturing infrastructure. Additionally, the region benefits from favorable regulatory support, rapid adoption of single-use technologies, and increasing demand for biologics and cell & gene therapies, further strengthening its market leadership.
  • In the product type segment of the biopharmaceutical processing equipment & consumables market, the filtration systems category is estimated to account for the largest market share in 2025.

Factors Contributing to the Growth of the Biopharmaceutical Processing Equipment & Consumables Market

  • Rising demand for biologics & advanced therapies leading to a surge in biopharmaceutical processing equipment & consumables: The increasing adoption of biologics such as monoclonal antibodies, vaccines, recombinant proteins, and cell & gene therapies is the primary growth driver of this market. These therapies require complex and highly controlled manufacturing environments, which directly increases the demand for advanced bioprocessing equipment and consumables.
  • Growing prevalence of chronic & genetic diseases: The rising global burden of chronic diseases (cancer, autoimmune disorders) and rare genetic conditions is accelerating biologics development. This, in turn, is increasing the need for large-scale and small-batch biomanufacturing infrastructure, boosting equipment and consumables demand.
  • Rapid growth of cell & gene therapy and personalized medicine: Emerging therapies such as CAR-T, gene therapy, and personalized medicine require Small-batch, high-value production, Closed and sterile systems, Flexible and modular equipment. This is significantly increasing demand for single-use systems and specialized consumables, thereby boosting the overall market of biopharmaceutical processing equipment & consumables.

Biopharmaceutical Processing Equipment & Consumables Market Report Segmentation

This biopharmaceutical processing equipment & consumables market report offers a comprehensive overview of the global biopharmaceutical processing equipment & consumables market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product Type (Equipment's {Bioreactors, Filtration Systems, Chromatography Systems, Centrifuges & Separators, and Others} and Consumables), Workflow Stage (Upstream Processing, Downstream Processing, Formulation & Fill-Finish, and Quality Control & Analytical Testing), Application (Monoclonal Antibodies (mAbs), Vaccines, Recombinant Proteins, Cell & Gene Therapies, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing biopharmaceutical processing equipment & consumables market.

Biopharmaceutical processing equipment and consumables refer to the tools, systems, and disposable materials used to develop, manufacture, purify, and package biologic drugs such as vaccines, monoclonal antibodies, and cell & gene therapies. Equipment includes machines like bioreactors, filtration systems, and chromatography systems, while consumables consist of single-use items such as filters, resins, media, tubing, and bioprocess containers. Together, they enable efficient, scalable, and sterile production of biologics across upstream, downstream, and fill-finish stages.

The rising demand for biologics and advanced therapies, combined with the increasing prevalence of chronic and genetic diseases, is significantly accelerating the development and commercialization of complex treatments such as monoclonal antibodies, vaccines, and targeted therapies. As pharmaceutical pipelines increasingly shift toward biologics, which are more complex to produce than traditional small-molecule drugs, manufacturers require sophisticated and tightly controlled production environments. At the same time, the rapid growth of cell & gene therapy and personalized medicine is transforming manufacturing models, moving from large-scale, standardized production to smaller, patient-specific, and highly flexible systems that demand precision, sterility, and scalability.

Together, these trends are driving strong demand for advanced biopharmaceutical processing equipment such as bioreactors, filtration systems, and chromatography platforms, which are essential for cell cultivation, purification, and final product quality. In parallel, there is a growing reliance on high-quality consumables, including single-use assemblies, media, resins, and filtration components that support contamination-free operations, faster turnaround times, and cost-efficient manufacturing. Additionally, the shift toward single-use and modular technologies enables manufacturers to quickly adapt to changing production needs, reduce validation requirements, and enhance operational efficiency. As a result, the combined impact of these factors is significantly boosting investments in both equipment and consumables, strengthening the overall growth of the biopharmaceutical processing market.

What are the latest biopharmaceutical processing equipment & consumables market dynamics and trends?

The rising demand for biologics and advanced therapies is a major force accelerating the growth of the biopharmaceutical processing equipment & consumables market, as these therapies are inherently more complex, sensitive, and resource-intensive to manufacture than traditional small-molecule drugs. Biologics such as monoclonal antibodies, vaccines, and recombinant proteins require highly controlled environments, multi-step purification processes, and stringent sterility standards, which directly increases the need for advanced equipment like bioreactors, filtration systems, and chromatography platforms, along with high-quality consumables such as single-use assemblies, media, and resins. As the global biologics pipeline expands, manufacturers are scaling up production capacities and investing heavily in modern bioprocessing infrastructure.

For instance, in February 2025, Thermo Fisher Scientific announced a ~$4.1 billion acquisition of a purification and filtration business, strengthening its position in downstream bioprocessing and directly addressing the growing need for biologics purification technologies. Furthermore, in July 2025, the company also acquired a manufacturing site from Sanofi to expand sterile fill-finish capacity, reflecting increasing demand for large-scale biologics production.

Additionally, the increasing chronic and genetic disorders are further escalating the overall market of biopharmaceuticals processing equipment and consumables. According to the data provided by the International Agency for Research on Cancer (2026), there would be approximately 32.6 million new cases of cancer across the world by 2045. The increasing incidence of cancer is significantly boosting the biopharmaceutical processing equipment & consumables market, as oncology remains one of the largest application areas for biologics such as monoclonal antibodies, immunotherapies, and cell-based treatments. As more cancer cases are diagnosed globally, there is a growing need for advanced and targeted therapies, which in turn drives higher production of biologics. This increases demand for sophisticated processing equipment like bioreactors, filtration, and chromatography systems, as well as consumables such as single-use assemblies, media, and resins. Additionally, the rise of personalized cancer treatments, including CAR-T therapies, further accelerates the need for flexible, sterile, and scalable biomanufacturing solutions, thereby supporting overall market growth. Thus, the factors mentioned above are expected to boost the overall market of biopharmaceutical processing equipment & consumables during the forecast period.

However, the risk of contamination and product loss, along with regulatory and compliance complexity, acts as a significant limiting factor in the biopharmaceutical processing equipment & consumables market. Biologics manufacturing is highly sensitive, and even minor contamination can lead to complete batch failure, resulting in substantial financial losses and production delays. This necessitates the stringent use of high-quality equipment and consumables, increasing costs and operational burden. At the same time, strict regulatory requirements from agencies such as the FDA and EMA demand extensive validation, documentation, and quality assurance processes for both equipment and consumables, making implementation time-consuming and expensive. Together, these factors can slow down adoption, particularly for smaller manufacturers, and create barriers to efficient and scalable bioproduction.

Biopharmaceutical Processing Equipment & Consumables Market Segment Analysis

Biopharmaceutical Processing Equipment & Consumables Market by Product Type (Equipment's {Bioreactors, Filtration Systems, Chromatography Systems, Centrifuges & Separators, and Others} and Consumables), Workflow Stage (Upstream Processing, Downstream Processing, Formulation & Fill-Finish, and Quality Control & Analytical Testing), Application (Monoclonal Antibodies (mAbs), Vaccines, Recombinant Proteins, Cell & Gene Therapies, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Biopharmaceutical Processing Equipment & Consumables Market Regional Analysis

North America Biopharmaceutical Processing Equipment & Consumables Market Trends

North America is expected to account for the highest proportion of 38% of the Biopharmaceutical Processing Equipment & Consumables market in 2025, out of all regions. North America is expected to dominate the biopharmaceutical processing equipment & consumables market due to its highly developed biopharmaceutical ecosystem, strong presence of leading manufacturers, advanced manufacturing infrastructure, and continuous investments in biologics production and innovation. The region, particularly the United States, has a large concentration of biopharmaceutical and biotechnology companies, which are the primary end users of bioprocessing equipment and consumables and purchase these products in significant volumes for both clinical and commercial-scale production. Additionally, strong government support for biotechnology and biomanufacturing, along with increasing demand for biologics such as monoclonal antibodies, vaccines, and cell & gene therapies, is driving the continuous expansion of production capacity and adoption of advanced technologies like single-use systems and automated bioprocessing platforms. The region also benefits from a well-established supply chain, availability of skilled workforce, and rapid adoption of innovative solutions, which further strengthen its leadership position.

This dominance is further supported by recent company-specific developments in North America, highlighting ongoing investments and capacity expansion. For instance, in June 2025, Cytiva completed part of its $1.6 billion global investment program, including expansions in the United States to enhance bioprocessing manufacturing capabilities, reflecting strong regional demand for equipment and consumables.

Furthermore, companies such as Danaher Corporation and Thermo Fisher Scientific continue to strengthen their presence in the region through technological advancements and infrastructure investments aimed at supporting next-generation therapies. These continuous investments, coupled with strong biologics demand and innovation, reinforce North America's dominant position in the global biopharmaceutical processing equipment & consumables market.

Europe Biopharmaceutical Processing Equipment & Consumables Market Trend

The biopharmaceutical processing equipment & consumables market in Europe is witnessing strong and sustained growth due to the region's robust biopharmaceutical manufacturing base, increasing investments in biologics production, and a strong regulatory and innovation ecosystem. Europe is home to several leading bioprocessing solution providers such as Sartorius AG and Cytiva, along with a well-established network of pharmaceutical companies and CDMOs, which are continuously expanding their manufacturing capabilities to meet the growing demand for biologics, vaccines, and advanced therapies. Additionally, supportive regulatory frameworks and increasing focus on sustainable and continuous bioprocessing technologies are encouraging the adoption of advanced equipment and high-value consumables across the region. The presence of a skilled workforce, strong R&D infrastructure, and rising outsourcing of manufacturing activities further contribute to market expansion.

This growth is further supported by recent company-specific developments across Europe. For instance, in June 2025, Cytiva completed major capacity expansions, including significantly increasing chromatography resin production in Uppsala, Sweden, to strengthen regional supply chains and meet rising biologics demand. Similarly, in February 2026, Sartorius AG announced that it invested approximately EUR 442 million in expanding its bioprocess production capabilities, including facilities in Europe, with a focus on advanced filtration technologies and sustainable solutions. In another development, in September 2024, PCI Pharma Services announced the expansion of its packaging and device assembly facilities in Dublin, Ireland, aimed at enhancing commercial-scale biologics packaging and cold chain capabilities.

These ongoing investments and infrastructure expansions across key European countries highlight the region's commitment to strengthening its biomanufacturing capabilities, thereby driving sustained growth in the biopharmaceutical processing equipment & consumables market.

Asia-Pacific Biopharmaceutical Processing Equipment & Consumables Market Trends

The Asia Pacific (APAC) region is emerging as a major growth driver for the biopharmaceutical processing equipment & consumables market due to its rapid expansion of biopharmaceutical manufacturing capabilities, increasing investments in biotechnology, and growing demand for biologics and biosimilars. Countries such as China, India, South Korea, and Japan are witnessing significant growth in local biopharma production, supported by government initiatives, favorable regulatory policies, and cost advantages in manufacturing. The rising presence of contract development and manufacturing organizations (CDMOs), along with increasing clinical trial activities and expanding healthcare infrastructure, is further boosting demand for advanced bioprocessing equipment and consumables. Additionally, global players such as Samsung Biologics and WuXi AppTec are heavily investing in large-scale biologics manufacturing facilities in the region, strengthening supply chains and accelerating the adoption of single-use technologies and modern bioprocessing systems. Together, these factors are positioning APAC as a key high-growth region in the global market.

Who are the major players in the biopharmaceutical processing equipment & consumables market?

The following are the leading companies in the biopharmaceutical processing equipment & consumables market. These companies collectively hold the largest market share and dictate industry trends.

  • Thermo Fisher Scientific Inc.
  • Sartorius AG
  • Cytiva
  • Merck KGaA
  • Eppendorf SE
  • Lonza Group AG
  • Repligen Corporation
  • Avantor, Inc.
  • Corning Incorporated
  • Danaher Corporation
  • Getinge AB
  • GEA Group AG
  • ABEC, Inc.
  • PBS Biotech, Inc.
  • Meissner Filtration Products, Inc.
  • Entegris, Inc.
  • Saint-Gobain Life Sciences
  • Parker-Hannifin Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Others

How is the competitive landscape shaping the biopharmaceutical processing equipment & consumables market?

The competitive landscape of the biopharmaceutical processing equipment & consumables market is characterized by a moderately consolidated structure, where a few global leaders dominate core technologies while a broader base of mid-sized and regional players intensifies competition in niche and consumables segments. Major companies such as Thermo Fisher Scientific, Danaher (including Cytiva), Merck KGaA, and Sartorius AG hold strong market positions due to their comprehensive product portfolios spanning bioreactors, filtration systems, chromatography, and single-use technologies, along with global manufacturing and distribution capabilities. These players compete primarily through technological innovation, integrated solutions, and long-term service contracts, often offering end-to-end bioprocessing platforms that increase customer dependency and switching costs. At the same time, competition is becoming increasingly dynamic as mid-tier companies and emerging players focus on specialized areas such as cell & gene therapy, single-use consumables, and modular systems, challenging established leaders with cost-effective and flexible solutions.

In addition, the market is witnessing intense strategic activities such as mergers & acquisitions, partnerships with CDMOs, and capacity expansions, as companies aim to strengthen their technological capabilities and expand their geographic footprint. Innovation in areas such as automation, digital bioprocessing, continuous manufacturing, and closed-system technologies is becoming a key differentiator, with companies investing heavily in R&D to enhance process efficiency and scalability. Furthermore, increasing competition from low-cost manufacturers, particularly in Asia, is putting pricing pressure on established players, prompting them to differentiate through value-added services, quality assurance, and advanced analytics integration. Overall, the competitive landscape is evolving toward a mix of consolidation among large players and innovation-driven competition from emerging companies, which is collectively shaping market growth, technological advancement, and strategic positioning in the biopharmaceutical processing equipment & consumables market.

Recent Developmental Activities in the Biopharmaceutical Processing Equipment & Consumables Market

  • In February 2026, Sartorius AG announced that it invested approximately EUR 442 million in expanding its bioprocess production capabilities, including facilities in Europe, with a focus on advanced filtration technologies and sustainable solutions.
  • In February 2025, Thermo Fisher Scientific announced a ~$4.1 billion acquisition of a purification and filtration business, strengthening its position in downstream bioprocessing and directly addressing the growing need for biologics purification technologies.
  • In July 2025, Thermo Fisher Scientific acquired a manufacturing site from Sanofi to expand sterile fill-finish capacity, reflecting increasing demand for large-scale biologics production.

Biopharmaceutical Processing Equipment & Consumables Market Segmentation

  • Biopharmaceutical Processing Equipment & Consumables by Product Type Exposure
  • Equipment's
  • Bioreactors
  • Filtration Systems
  • Chromatography Systems
  • Centrifuges & Separators
  • Others
  • Consumables
  • Biopharmaceutical Processing Equipment & Consumables by Workflow Stage Exposure
  • Upstream Processing
  • Downstream Processing
  • Formulation & Fill-Finish
  • Quality Control & Analytical Testing
  • Biopharmaceutical Processing Equipment & Consumables Application Exposure
  • Monoclonal Antibodies (mAbs)
  • Vaccines
  • Recombinant Proteins
  • Cell & Gene Therapies
  • Others
  • Biopharmaceutical Processing Equipment & Consumables End-Users Exposure
  • Biopharmaceutical & Pharmaceutical Companies
  • Contract Development & Manufacturing Organizations (CDMOs)
  • Academic & Research Institutes
  • Biopharmaceutical Processing Equipment & Consumables Geography Exposure
  • North America Biopharmaceutical Processing Equipment & Consumables Market
  • United States Biopharmaceutical Processing Equipment & Consumables Market
  • Canada Biopharmaceutical Processing Equipment & Consumables Market
  • Mexico Biopharmaceutical Processing Equipment & Consumables Market
  • Europe Biopharmaceutical Processing Equipment & Consumables Market
  • United Kingdom Biopharmaceutical Processing Equipment & Consumables Market
  • Germany Biopharmaceutical Processing Equipment & Consumables Market
  • France Biopharmaceutical Processing Equipment & Consumables Market
  • Italy Biopharmaceutical Processing Equipment & Consumables Market
  • Spain Biopharmaceutical Processing Equipment & Consumables Market
  • Rest of Europe Biopharmaceutical Processing Equipment & Consumables Market
  • Asia-Pacific Biopharmaceutical Processing Equipment & Consumables Market
  • China Biopharmaceutical Processing Equipment & Consumables Market
  • Japan Biopharmaceutical Processing Equipment & Consumables Market
  • India Biopharmaceutical Processing Equipment & Consumables Market
  • Australia Biopharmaceutical Processing Equipment & Consumables Market
  • South Korea Biopharmaceutical Processing Equipment & Consumables Market
  • Rest of Asia-Pacific Biopharmaceutical Processing Equipment & Consumables Market
  • Rest of the World Biopharmaceutical Processing Equipment & Consumables Market
  • South America Biopharmaceutical Processing Equipment & Consumables Market
  • Middle East Biopharmaceutical Processing Equipment & Consumables Market
  • Africa Biopharmaceutical Processing Equipment & Consumables Market

Impact Analysis

AI-Powered Innovations and Applications:

AI-powered innovations are rapidly transforming biopharmaceutical processing equipment & consumables by enabling smarter, faster, and more efficient manufacturing across the entire bioprocessing workflow. Artificial intelligence (AI) and machine learning (ML) are being integrated with equipment such as bioreactors, filtration systems, and analytical instruments to enable real-time process monitoring, predictive control, and automated decision-making. For instance, AI-driven "soft sensors" combine data from multiple sources to estimate critical parameters like cell density, metabolite levels, and product quality attributes, allowing early intervention and improved process stability. In upstream processing, AI models optimize cell culture conditions (e.g., temperature, pH, nutrient levels) to maximize yield and reduce batch failures, while in downstream processes, AI enhances purification efficiency and process consistency.

Additionally, AI is widely used for predictive maintenance of bioprocessing equipment, where algorithms analyze sensor and IoT data to forecast equipment failures and minimize downtime, thereby improving operational efficiency. In quality control, AI-powered computer vision and anomaly detection systems automate inspection, ensuring compliance with stringent regulatory standards and reducing human error. Emerging applications such as digital twins, generative AI, and advanced analytics platforms are further enabling simulation-based process optimization, demand forecasting, and supply chain management, leading to reduced costs and improved scalability. Overall, AI-powered innovations are playing a critical role in advancing biopharmaceutical processing by enhancing efficiency, product quality, regulatory compliance, and flexibility, making them a key driver of next-generation biomanufacturing systems.

U.S. Tariff Impact Analysis on Biopharmaceutical Processing Equipment & Consumables Market:

The U.S. tariff impact on the biopharmaceutical processing equipment & consumables market is creating a complex mix of cost pressures, supply chain disruptions, and strategic realignments across the industry. Recent tariff policies, including a baseline ~10% import tariff and significantly higher country-specific duties (ranging up to 20-50% or more) on medical equipment and industrial inputs, are increasing the cost of imported bioprocessing equipment, components, and consumables such as filters, tubing, and single-use systems. These higher input costs directly affect manufacturers and CDMOs, as the biopharmaceutical sector relies heavily on globally integrated supply chains for raw materials, components, and specialized equipment.

In addition, policy actions such as the proposed 100% tariff on branded pharmaceutical imports (effective October 2025 unless companies invest in U.S. manufacturing) are pushing companies to reshore production and expand domestic manufacturing facilities, which in turn is increasing demand for locally sourced bioprocessing equipment and consumables. However, this shift also creates short-term challenges, including higher capital expenditure, longer setup timelines, and supply bottlenecks, particularly for companies dependent on imported technologies. Tariffs are also contributing to operational uncertainty and pricing volatility, forcing companies to rethink sourcing strategies, diversify suppliers, and invest in regional manufacturing hubs.

Overall, while U.S. tariffs are raising costs and disrupting global supply chains, they are simultaneously encouraging domestic manufacturing, localization of supply chains, and long-term investment in U.S.-based bioprocessing infrastructure, thereby reshaping the competitive dynamics and growth trajectory of the biopharmaceutical processing equipment & consumables market.

How This Analysis Helps Clients

  • Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
  • Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
  • Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
  • Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the biopharmaceutical processing equipment & consumables market report study

  • Market size analysis for the current biopharmaceutical processing equipment & consumables market size (2025), and market forecast for 8 years (2026 to 2034)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the biopharmaceutical processing equipment & consumables market.
  • Various opportunities available for the other competitors in the biopharmaceutical processing equipment & consumables market space.
  • What are the top-performing segments in 2025? How these segments will perform in 2034?
  • Which are the top-performing regions and countries in the current biopharmaceutical processing equipment & consumables market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for the biopharmaceutical processing equipment & consumables market growth in the future.

Frequently Asked Questions for the Biopharmaceutical Processing Equipment & Consumables Market

1. What is the growth rate of the biopharmaceutical processing equipment & consumables market?

  • The biopharmaceutical processing equipment & consumables market is estimated to grow at a CAGR of 9.38% during the forecast period from 2026 to 2034.

2. What is the market for biopharmaceutical processing equipment & consumables?

  • The global biopharmaceutical processing equipment & consumables market is expected to increase from USD 52,172.43 million in 2025 to USD 116,456.28 million by 2034.

3. Which region has the highest share in the biopharmaceutical processing equipment & consumables market?

  • North America is expected to dominate the biopharmaceutical processing equipment & consumables market due to its well-established biopharmaceutical industry, strong presence of leading manufacturers such as Thermo Fisher Scientific, Danaher Corporation, and Cytiva, high R&D investments, and advanced manufacturing infrastructure. Additionally, the region benefits from favorable regulatory support, rapid adoption of single-use technologies, and increasing demand for biologics and cell & gene therapies, further strengthening its market leadership.

4. What are the drivers for the biopharmaceutical processing equipment & consumables market?

  • The rising demand for biologics and advanced therapies, combined with the increasing prevalence of chronic and genetic diseases, is significantly accelerating the development and commercialization of complex treatments such as monoclonal antibodies, vaccines, and targeted therapies. At the same time, the rapid growth of cell & gene therapy and personalized medicine is shifting manufacturing toward smaller, highly specialized, and flexible production systems. Together, these trends are driving strong demand for advanced biopharmaceutical processing equipment such as bioreactors, filtration, and chromatography systems, as well as high-quality consumables like single-use assemblies, media, and resins, as manufacturers require scalable, sterile, and efficient solutions to meet evolving therapeutic needs.

5. Who are the key players operating in the biopharmaceutical processing equipment & consumables market?

  • Some of the key market players operating in the biopharmaceutical processing equipment & consumables market include Thermo Fisher Scientific Inc., Sartorius AG, Cytiva, Merck KGaA, Eppendorf SE, Lonza Group AG, Repligen Corporation, Avantor, Inc., Corning Incorporated, Danaher Corporation, Getinge AB, GEA Group AG, ABEC, Inc., PBS Biotech, Inc., Meissner Filtration Products, Inc., Entegris, Inc., Saint-Gobain Life Sciences, Parker-Hannifin Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., and others.

Table of Contents

1. Biopharmaceutical Processing Equipment & Consumables Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumption

2. Biopharmaceutical Processing Equipment & Consumables Market Executive Summary

  • 2.1 Market at Glance

3. Biopharmaceutical Processing Equipment & Consumables Market Key Factors Analysis

  • 3.1 Biopharmaceutical Processing Equipment & Consumables Market Drivers
    • 3.1.1 Rising demand for biologics & advanced therapies
    • 3.1.2 Growing prevalence of chronic & genetic diseases
    • 3.1.3 Rapid growth of cell & gene therapy and personalized medicine
  • 3.2 Biopharmaceutical Processing Equipment & Consumables Market Restraints and Challenges
    • 3.2.1 Risk of contamination & product loss
    • 3.2.2 Regulatory & compliance complexity
  • 3.3 Biopharmaceutical Processing Equipment & Consumables Market Opportunity
    • 3.3.1 Integration of AI, automation & digital bioprocessing

4. Impact Analysis

  • 4.1 AI-Powered Innovations and Applications
  • 4.2 U.S. Tariff Impact Analysis

5. Regulatory Analysis

  • 5.1 The United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Biopharmaceutical Processing Equipment & Consumables Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Consumers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Biopharmaceutical Processing Equipment & Consumables Market Assessment

  • 7.1 By Product Type
    • 7.1.1 Equipment's
      • 7.1.1.1 Bioreactors
      • 7.1.1.2 Filtration Systems
      • 7.1.1.3 Chromatography Systems
      • 7.1.1.4 Centrifuges & Separators
      • 7.1.1.5 Others
    • 7.1.2 Consumables
  • 7.2 By Workflow Stage
    • 7.2.1 Upstream Processing
    • 7.2.2 Downstream Processing
    • 7.2.3 Formulation & Fill-Finish
    • 7.2.4 Quality Control & Analytical Testing
  • 7.3 By Application
    • 7.3.1 Monoclonal Antibodies (mAbs)
    • 7.3.2 Vaccines
    • 7.3.3 Recombinant Proteins
    • 7.3.4 Cell & Gene Therapies
    • 7.3.5 Others
  • 7.4 By End-Users
    • 7.4.1 Biopharmaceutical & Pharmaceutical Companies
    • 7.4.2 Contract Development & Manufacturing Organizations (CDMOs)
    • 7.4.3 Academic & Research Institutes
  • 7.5 By Geography
    • 7.5.1 North America
      • 7.5.1.1 United States Biopharmaceutical Processing Equipment & Consumables Market Size in USD million (2023-2034)
      • 7.5.1.2 Canada Biopharmaceutical Processing Equipment & Consumables Market Size in USD million (2023-2034)
      • 7.5.1.3 Mexico Biopharmaceutical Processing Equipment & Consumables Market Size in USD million (2023-2034)
    • 7.5.2 Europe
      • 7.5.2.1 France Biopharmaceutical Processing Equipment & Consumables Market Size in USD million (2023-2034)
      • 7.5.2.2 Germany Biopharmaceutical Processing Equipment & Consumables Market Size in USD million (2023-2034)
      • 7.5.2.3 United Kingdom Biopharmaceutical Processing Equipment & Consumables Market Size in USD million (2023-2034)
      • 7.5.2.4 Italy Biopharmaceutical Processing Equipment & Consumables Market Size in USD million (2023-2034)
      • 7.5.2.5 Spain Biopharmaceutical Processing Equipment & Consumables Market Size in USD million (2023-2034)
      • 7.5.2.6 Rest of Europe Biopharmaceutical Processing Equipment & Consumables Market Size in USD million (2023-2034)
    • 7.5.3 Asia-Pacific
      • 7.5.3.1 China Biopharmaceutical Processing Equipment & Consumables Market Size in USD million (2023-2034)
      • 7.5.3.2 Japan Biopharmaceutical Processing Equipment & Consumables Market Size in USD million (2023-2034)
      • 7.5.3.3 India Biopharmaceutical Processing Equipment & Consumables Market Size in USD million (2023-2034)
      • 7.5.3.4 Australia Biopharmaceutical Processing Equipment & Consumables Market Size in USD million (2023-2034)
      • 7.5.3.5 South Korea Biopharmaceutical Processing Equipment & Consumables Market Size in USD million (2023-2034)
      • 7.5.3.6 Rest of Asia-Pacific Biopharmaceutical Processing Equipment & Consumables Market Size in USD million (2023-2034)
    • 7.5.4 Rest of the World (RoW)
      • 7.5.4.1 Middle East Biopharmaceutical Processing Equipment & Consumables Market Size in USD million (2023-2034)
      • 7.5.4.2 Africa Biopharmaceutical Processing Equipment & Consumables Market Size in USD million (2023-2034)
      • 7.5.4.3 South America Biopharmaceutical Processing Equipment & Consumables Market Size In USD Million (2023-2034)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Biopharmaceutical Processing Equipment & Consumables Market Company and Product Profiles

  • 10.1 Thermo Fisher Scientific Inc.
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Product Listing
    • 10.1.5 Entropy
  • 10.2 Sartorius AG
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Listing
    • 10.2.5 Entropy
  • 10.3 Cytiva (Danaher Corporation)
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Listing
    • 10.3.5 Entropy
  • 10.4 Merck KGaA
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Listing
    • 10.4.5 Entropy
  • 10.5 Eppendorf SE
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Listing
    • 10.5.5 Entropy
  • 10.6 Lonza Group AG
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Listing
    • 10.6.5 Entropy
  • 10.7 Repligen Corporation
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Listing
    • 10.7.5 Entropy
  • 10.8 Avantor, Inc.
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Listing
    • 10.8.5 Entropy
  • 10.9 Corning Incorporated
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Listing
    • 10.9.5 Entropy
  • 10.10 Danaher Corporation
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Listing
    • 10.10.5 Entropy
  • 10.11 Getinge AB
    • 10.11.1 Company Overview
    • 10.11.2 Company Snapshot
    • 10.11.3 Financial Overview
    • 10.11.4 Product Listing
    • 10.11.5 Entropy
  • 10.12 GEA Group AG
    • 10.12.1 Company Overview
    • 10.12.2 Company Snapshot
    • 10.12.3 Financial Overview
    • 10.12.4 Product Listing
    • 10.12.5 Entropy
  • 10.13 ABEC, Inc.
    • 10.13.1 Company Overview
    • 10.13.2 Company Snapshot
    • 10.13.3 Financial Overview
    • 10.13.4 Product Listing
    • 10.13.5 Entropy
  • 10.14 PBS Biotech, Inc.
    • 10.14.1 Company Overview
    • 10.14.2 Company Snapshot
    • 10.14.3 Financial Overview
    • 10.14.4 Product Listing
    • 10.14.5 Entropy
  • 10.15 Meissner Filtration Products, Inc.
    • 10.15.1 Company Overview
    • 10.15.2 Company Snapshot
    • 10.15.3 Financial Overview
    • 10.15.4 Product Listing
    • 10.15.5 Entropy
  • 10.16 Entegris, Inc.
    • 10.16.1 Company Overview
    • 10.16.2 Company Snapshot
    • 10.16.3 Financial Overview
    • 10.16.4 Product Listing
    • 10.16.5 Entropy
  • 10.17 Saint-Gobain Life Sciences
    • 10.17.1 Company Overview
    • 10.17.2 Company Snapshot
    • 10.17.3 Financial Overview
    • 10.17.4 Product Listing
    • 10.17.5 Entropy
  • 10.18 Parker-Hannifin Corporation
    • 10.18.1 Company Overview
    • 10.18.2 Company Snapshot
    • 10.18.3 Financial Overview
    • 10.18.4 Product Listing
    • 10.18.5 Entropy
  • 10.19 Agilent Technologies, Inc.
    • 10.19.1 Company Overview
    • 10.19.2 Company Snapshot
    • 10.19.3 Financial Overview
    • 10.19.4 Product Listing
    • 10.19.5 Entropy
  • 10.20 Bio-Rad Laboratories, Inc.
    • 10.20.1 Company Overview
    • 10.20.2 Company Snapshot
    • 10.20.3 Financial Overview
    • 10.20.4 Product Listing
    • 10.20.5 Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us

List of Tables

  • Table 1: Biopharmaceutical Processing Equipment & Consumables Market in Global (2023-2034)
  • Table 2: Biopharmaceutical Processing Equipment & Consumables Market in Global by Product Type (2023-2034)
  • Table 3: Biopharmaceutical Processing Equipment & Consumables Market in Global by Workflow Stage (2023-2034)
  • Table 4: Biopharmaceutical Processing Equipment & Consumables Market in Global by Application (2023-2034)
  • Table 5: Biopharmaceutical Processing Equipment & Consumables Market in Global by End-Users (2023-2034)
  • Table 6: Biopharmaceutical Processing Equipment & Consumables Market in Global by Geography (2023-2034)
  • Table 7: Biopharmaceutical Processing Equipment & Consumables Market in North America (2023-2034)
  • Table 8: Biopharmaceutical Processing Equipment & Consumables Market in the United States (2023-2034)
  • Table 9: Biopharmaceutical Processing Equipment & Consumables Market in Canada (2023-2034)
  • Table 10: Biopharmaceutical Processing Equipment & Consumables Market in Mexico (2023-2034)
  • Table 11: Biopharmaceutical Processing Equipment & Consumables Market in Europe (2023-2034)
  • Table 12: Biopharmaceutical Processing Equipment & Consumables Market in France (2023-2034)
  • Table 13: Biopharmaceutical Processing Equipment & Consumables Market in Germany (2023-2034)
  • Table 14: Biopharmaceutical Processing Equipment & Consumables Market in United Kingdom (2023-2034)
  • Table 15: Biopharmaceutical Processing Equipment & Consumables Market in Italy (2023-2034)
  • Table 16: Biopharmaceutical Processing Equipment & Consumables Market in Spain (2023-2034)
  • Table 17: Biopharmaceutical Processing Equipment & Consumables Market in the Rest of Europe (2023-2034)
  • Table 18: Biopharmaceutical Processing Equipment & Consumables Market in Asia-Pacific (2023-2034)
  • Table 19: Biopharmaceutical Processing Equipment & Consumables Market in China (2023-2034)
  • Table 20: Biopharmaceutical Processing Equipment & Consumables Market in Japan (2023-2034)
  • Table 21: Biopharmaceutical Processing Equipment & Consumables Market in India (2023-2034)
  • Table 22: Biopharmaceutical Processing Equipment & Consumables Market in Australia (2023-2034)
  • Table 23: Biopharmaceutical Processing Equipment & Consumables Market in South Korea (2023-2034)
  • Table 24: Biopharmaceutical Processing Equipment & Consumables Market in Rest of Asia-Pacific (2023-2034)
  • Table 25: Biopharmaceutical Processing Equipment & Consumables Market in the Rest of the World (2023-2034)
  • Table 26: Biopharmaceutical Processing Equipment & Consumables Market in the Middle East (2023-2034)
  • Table 27: Biopharmaceutical Processing Equipment & Consumables Market in Africa (2023-2034)
  • Table 28: Biopharmaceutical Processing Equipment & Consumables Market in South America (2023-2034)
  • Table 29: Competitive Landscape
  • Table 30: Startup Funding & Investment Trends

List of Figures

  • Figure 1: Biopharmaceutical Processing Equipment & Consumables Market Drivers
  • Figure 2: Biopharmaceutical Processing Equipment & Consumables Market Restraints
  • Figure 3: Biopharmaceutical Processing Equipment & Consumables Market Opportunities
  • Figure 4: AI-Powered Innovations in Biopharmaceutical Processing Equipment & Consumables Market
  • Figure 5: US Tariff Impact on Biopharmaceutical Processing Equipment & Consumables Market
  • Figure 6: Regulatory Analysis (US, EU, Japan, China)
  • Figure 7: Porter's Five Forces Analysis
  • Figure 8: Competitive Analysis
  • Figure 9: Biopharmaceutical Processing Equipment & Consumables Market in Global (2023-2034)
  • Figure 10: Biopharmaceutical Processing Equipment & Consumables Market in Global by Product Type (2023-2034)
  • Figure 11: Biopharmaceutical Processing Equipment & Consumables Market in Global by Workflow Stage (2023-2034)
  • Figure 12: Biopharmaceutical Processing Equipment & Consumables Market in Global by Application (2023-2034)
  • Figure 13: Biopharmaceutical Processing Equipment & Consumables Market in Global by End-Users (2023-2034)
  • Figure 14: Biopharmaceutical Processing Equipment & Consumables Market in Global by Geography (2023-2034)
  • Figure 15: Biopharmaceutical Processing Equipment & Consumables Market in North America (2023-2034)
  • Figure 16: Biopharmaceutical Processing Equipment & Consumables Market in the United States (2023-2034)
  • Figure 17: Biopharmaceutical Processing Equipment & Consumables Market in Canada (2023-2034)
  • Figure 18: Biopharmaceutical Processing Equipment & Consumables Market in Mexico (2023-2034)
  • Figure 19: Biopharmaceutical Processing Equipment & Consumables Market in Europe (2023-2034)
  • Figure 20: Biopharmaceutical Processing Equipment & Consumables Market in France (2023-2034)
  • Figure 21: Biopharmaceutical Processing Equipment & Consumables Market in Germany (2023-2034)
  • Figure 22: Biopharmaceutical Processing Equipment & Consumables Market in United Kingdom (2023-2034)
  • Figure 23: Biopharmaceutical Processing Equipment & Consumables Market in Italy (2023-2034)
  • Figure 24: Biopharmaceutical Processing Equipment & Consumables Market in Spain (2023-2034)
  • Figure 25: Biopharmaceutical Processing Equipment & Consumables Market in the Rest of Europe (2023-2034)
  • Figure 26: Biopharmaceutical Processing Equipment & Consumables Market in Asia-Pacific (2023-2034)
  • Figure 27: Biopharmaceutical Processing Equipment & Consumables Market in China (2023-2034)
  • Figure 28: Biopharmaceutical Processing Equipment & Consumables Market in Japan (2023-2034)
  • Figure 29: Biopharmaceutical Processing Equipment & Consumables Market in India (2023-2034)
  • Figure 30: Biopharmaceutical Processing Equipment & Consumables Market in Australia (2023-2034)
  • Figure 31: Biopharmaceutical Processing Equipment & Consumables Market in South Korea (2023-2034)
  • Figure 32: Biopharmaceutical Processing Equipment & Consumables Market in Rest of Asia-Pacific (2023-2034)
  • Figure 33: Biopharmaceutical Processing Equipment & Consumables Market in the Rest of the World (2023-2034)
  • Figure 34: Biopharmaceutical Processing Equipment & Consumables Market in the Middle East (2023-2034)
  • Figure 35: Biopharmaceutical Processing Equipment & Consumables Market in Africa (2023-2034)
  • Figure 36: Biopharmaceutical Processing Equipment & Consumables Market in South America (2023-2034)
  • Figure 37: Competitive Landscape
  • Figure 38: Startup Funding & Investment Trends